AIBS Provides Comments on U.S. Bioeconomy

The American Institute of Biological Sciences (AIBS) provided comments on the U.S. bioeconomy to the White House Office of Science and Technology Policy (OSTP), which recently issued a call for public input. The OSTP has initiated a process to gather input to help inform “notable gaps, vulnerabilities, and areas to promote and protect in the U.S. Bioeconomy that may benefit from Federal government attention.” Bioeconomy is defined as the infrastructure, innovation, products, technology, and data derived from biologically-related processes and science that drive economic growth, promote health, and increase public benefit. AIBS commended OSTP and the Office of Management and Budget for recognizing the importance of the bioeconomy and scientific collections in this year’s science and technology funding priorities guidance to federal departments and agencies, and called on OSTP to coordinate a government-wide initiative to build the Extended Specimen Network or ESN. “Existing specimens are extended through digitization and linkages with associated data, including genetic, phenotypic, behavioral, and environmental. New specimens will be collected with these extended attributes in mind. Combined with and even driving data integration technologies and relevant data layers, extended specimens will form the core of a powerful new research and education network. When fully realized, the Extended Specimen Network will support innovative new research in such a...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news